Disease severity and prefrontal cortex activation during obstacle negotiation among patients with Parkinson's disease: Is it all as expected?

被引:1
|
作者
Assad, M. [1 ,2 ]
Galperin, I [1 ,2 ]
Giladi, N. [1 ,3 ,4 ]
Mirelman, A. [1 ,3 ,4 ]
Hausdorff, J. M. [1 ,4 ,5 ,6 ,7 ]
Maidan, I [1 ,3 ,4 ]
机构
[1] Tel Aviv Sourasky Med Ctr, Lab Early Markers Neurodegenerat, Ctr Study Movement Cognit & Mobil, Neurol Inst, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Sch Med, Dept Neurol, Tel Aviv, Israel
[4] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, Tel Aviv, Israel
[6] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL USA
[7] Rush Univ, Med Ctr, Dept Orthopaed Surg, Chicago, IL USA
基金
以色列科学基金会;
关键词
Prefrontal cortex; fNIRS; Obstacle negotiation; Available response time; BRAIN ACTIVATION; COMPLEX WALKING; OLDER-ADULTS; ATTENTION; SIZE;
D O I
10.1016/j.parkreldis.2022.06.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Previous reports indicate that patients with Parkinson's disease (PD) activate the prefrontal cortex (PFC) during complex activities such as obstacle negotiation to compensate for impaired motor function. However, the influence of disease severity on PFC activation has not been systematically evaluated. Here, we examined the effects of disease severity on PFC activation during obstacle negotiation. Methods: 74 patients with PD (age 68.26 +/- 7.54 yrs; 62.2% men) were divided into three groups based on Hoehn and Yahr stages. All patients walked along an obstacle course while negotiating anticipated and unanticipated obstacles (long/low available response time) at heights of 50 mm and 100 mm. PFC activation was measured using functional near-infrared spectroscopy (fNIRS) and was compared between groups and tasks using mixed model analyses. Results: Participants with more advanced PD (i.e., Hoehn & Yahr 3) had higher PFC activation levels when negotiating anticipated obstacles, compared to participants with milder PD (i.e., Hoehn & Yahr 1, 2) (p < 0.001). Moreover, higher LEDD correlated with higher prefrontal activation during the higher anticipated obstacle. In contrast, during the negotiation of unanticipated obstacles, the differences in PFC activation were not associated with disease severity in a linear manner. Conclusions: The present study suggests that with increased disease severity, patients with PD rely more on the PFC when negotiating anticipated obstacles, perhaps to compensate for attention and motor deficits. These findings support the role of cognition in fall risk and the need to improve attention and cognition in fall prevention programs, especially among patients with more advanced disease.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 50 条
  • [41] Cost of Illness and Disease Severity in a Cohort of French Patients with Parkinson’s Disease
    Claude LePen
    Suzanne Wait
    Frédéric Moutard-Martin
    Max Dujardin
    Marc Ziégler
    PharmacoEconomics, 1999, 16 : 59 - 69
  • [42] Correlation between hemoglobin level and disease severity in patients with Parkinson's disease
    Gavriliuc, O.
    Rotaru, L.
    Gavriliuc, M.
    Caldarov, A.
    MOVEMENT DISORDERS, 2023, 38 : S607 - S607
  • [43] Relationship of irisin with disease severity and dopamine uptake in Parkinson's disease patients
    Shi, Xiaoxue
    Gu, Qi
    Fu, Chang
    Ma, Jianjun
    Li, Dongsheng
    Zheng, Jinhua
    Chen, Siyuan
    She, Zonghan
    Qi, Xuelin
    Li, Xue
    Wu, Shaopu
    Wang, Li
    NEUROIMAGE-CLINICAL, 2024, 41
  • [44] Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease
    Lanoue, Amelie C.
    Dumitriu, Alexandra
    Myers, Richard H.
    Soghomonian, Jean-Jacques
    EXPERIMENTAL NEUROLOGY, 2010, 226 (01) : 207 - 217
  • [45] Altered regional homogeneity of prefrontal cortex in Parkinson’s disease with mild cognitive impairment
    Kang DeZhi
    Chen FuXiang
    Chen FuYong
    Liu Ying
    Wu Gang
    Yu LiangHong
    Lin YuanXiang
    Lin ZhangYa
    中华神经外科杂志(英文), 2016, 2 (03)
  • [46] Factors Influencing Obstacle Crossing Performance in Patients with Parkinson's Disease
    Liao, Ying-Yi
    Yang, Yea-Ru
    Wu, Yih-Ru
    Wang, Ray-Yau
    PLOS ONE, 2014, 9 (01):
  • [47] Neural Variability in the Prefrontal Cortex as a Reflection of Neural Flexibility and Stability in Patients With Parkinson Disease
    Maidan, Inbal
    Hacham, Roni
    Galperin, Irina
    Giladi, Nir
    Holtzer, Roee
    Hausdorff, Jeffrey M.
    Mirelman, Anat
    NEUROLOGY, 2022, 98 (08) : E839 - E847
  • [48] Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients
    Burbaeva, GS
    Boksha, IS
    Tereshkina, EB
    Savushkina, OK
    Starodubtseva, LI
    Turishcheva, MS
    NEUROCHEMICAL RESEARCH, 2005, 30 (11) : 1443 - 1451
  • [49] Glutamate Metabolizing Enzymes in Prefrontal Cortex of Alzheimer’s Disease Patients
    Gulnur Sh. Burbaeva
    Irina S. Boksha
    Elena B. Tereshkina
    Olga K. Savushkina
    Lubov’ I. Starodubtseva
    Marina S. Turishcheva
    Neurochemical Research, 2005, 30 : 1443 - 1451
  • [50] Higher Activation of the Ventromedial Prefrontal Cortex During Mental Stress Predicts Major Cardiovascular Disease Events in Patients With Coronary Artery Disease
    Moazzami, Kasra
    Wittbrodt, Matthew T.
    Lima, Bruno B.
    Nye, Jonathon A.
    Mehta, Puja K.
    Quyyumi, Arshed A.
    Bremner, J. Douglas
    Shah, Amit J.
    Vaccarino, Viola
    CIRCULATION, 2019, 140